| Breakdown | TTM | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 178.73K | 209.04K | 222.05K | 113.89K | 146.76K | 190.35K |
| Gross Profit | 51.31K | 88.11K | 91.90K | -115.19K | 18.34K | 6.18K |
| EBITDA | -1.35M | -643.35K | -480.76K | -1.59M | -6.90M | -587.08K |
| Net Income | -1.59M | -970.02K | -738.66K | -1.68M | -6.95M | -622.85K |
Balance Sheet | ||||||
| Total Assets | 321.94K | 366.46K | 842.35K | 592.43K | 1.12M | 600.38K |
| Cash, Cash Equivalents and Short-Term Investments | 156.94K | 101.33K | 296.73K | 14.11K | 295.75K | 212.05K |
| Total Debt | 349.35K | 627.08K | 633.26K | 372.61K | 51.03K | 920.49K |
| Total Liabilities | 1.19M | 1.56M | 1.26M | 1.50M | 1.48M | 1.72M |
| Stockholders Equity | -808.22K | -1.20M | -412.95K | -1.20M | -364.10K | -1.12M |
Cash Flow | ||||||
| Free Cash Flow | -125.97K | -357.39K | -256.76K | -216.05K | -1.21M | -1.18M |
| Operating Cash Flow | -101.87K | -357.39K | -256.76K | -216.05K | -1.20M | -1.09M |
| Investing Cash Flow | -24.10K | 0.00 | 0.00 | 0.00 | 923.92K | -86.75K |
| Financing Cash Flow | 242.19K | 179.71K | 537.71K | -64.82K | 357.62K | 1.38M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
62 Neutral | $20.33B | 14.63 | -3.31% | 3.23% | 1.93% | -12.26% | |
46 Neutral | C$3.29M | -1.76 | ― | ― | -25.05% | -19.86% | |
43 Neutral | C$11.68M | -1.78 | -19.32% | ― | 556.60% | -198.67% | |
41 Neutral | C$3.77M | -3.77 | ― | ― | ― | -67.37% | |
26 Underperform | C$3.38M | ― | ― | ― | ― | ― | |
21 Underperform | $495.92K | -1.43 | ― | ― | ― | 69.96% |
CleanGo Innovations has launched its MycoSet oilfield remediation technology globally, positioning its Saudi Arabian subsidiary, CleanGo Arabia, at the center of expansion into Saudi Arabia and the wider Gulf Cooperation Council markets. The MycoSet suite, which includes the BioIngress biostimulant and PhytoCentra surfactant, is engineered to work in extreme arid and hypersaline environments and offers in‑situ hydrocarbon cleanup that the company says can outperform traditional mechanical and thermal methods while cutting logistics costs by up to 60% and water use by 85%. By emphasizing biological restoration of contaminated soils and aligning with regional partners such as Sanad Industrial Co., CleanGo aims to tap into tightening environmental regulations, support Saudi Vision 2030 objectives and establish a cost‑effective, nature‑based remediation standard for some of the world’s largest energy operators, potentially strengthening its competitive position in the global oilfield services and green technologies markets.
The most recent analyst rating on (TSE:CGII) stock is a Hold with a C$0.49 price target. To see the full list of analyst forecasts on CleanGo Innovations stock, see the TSE:CGII Stock Forecast page.
CleanGo Innovations Inc., through its subsidiary Kubera Black Technology, has entered a non-binding Letter of Intent to acquire Milan-based Freia Farmaceutici Srl, a European leader in plant-based therapeutics. This strategic move allows CleanGo to expand its reach into the global health sector, leveraging Freia’s expertise in vegetable omega-based medical devices, nutritional supplements, and innovative therapeutic solutions. The acquisition will grant Freia access to North American markets while providing CleanGo with diversified industry positioning and potential revenue growth opportunities.
CleanGo Innovations Inc. has announced a private placement to raise CAD 300,000 by issuing 500,000 units at CAD 0.60 each. This funding initiative involves both existing and new investors and is subject to regulatory and stock exchange approvals. The move is expected to bolster CleanGo’s financial position and support its mission to innovate in the green cleaning industry, potentially enhancing its market presence and stakeholder value.
CleanGo Innovations Inc. has entered the global environmental remediation market through a joint venture with Agritech BC. This strategic partnership aims to co-develop and commercialize Agritech’s bioremediation technologies, leveraging CleanGo’s international distribution networks. The collaboration positions the joint venture to address the growing demand for sustainable cleanup methods, with a focus on scaling key proprietary biotechnologies for environmental restoration projects worldwide. The joint venture is expected to capitalize on the rapidly growing bioremediation market, projected to reach USD $59.5 billion by 2034, and aims to establish a leadership position in providing ESG-compliant green infrastructure solutions.